Lentuo International Inc (ADR) (LAS), Nam Tai Electronics, Inc. (NTE), China Hgs Real Estate Inc (HGSH) Among The Top Five Losers On Monday

Editor’s note: Related tickers: Lentuo International Inc (ADR) (NYSE:LAS),  Nam Tai Electronics, Inc. (NYSE:NTE), China Hgs Real Estate Inc (NASDAQ:HGSH), Greenway Medical Technologies, Inc. (NYSE:GWAY), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

Even though there are price gainers and volume leaders, the top losers must also be watched. On Monday, the top five losers are: Lentuo International Inc (ADR) (NYSE:LAS),  Nam Tai Electronics, Inc. (NYSE:NTE), China Hgs Real Estate Inc (NASDAQ:HGSH), Greenway Medical Technologies, Inc. (NYSE:GWAY), and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX),

Lentuo International Inc (ADR) (NYSE:LAS) slid by 31.30% to $1.80 in deals worth $370,900. According to a statement on PRNewswire, Lentuo International Inc (ADR) (NYSE:LAS) today posted the financial results for the fourth quarter of 2012 and for the entire last year. The revenue in the fourth quarter fell by 15.4% on the year to $140.8 million, while the net loss totalled $3.9 million, compared to a profit of $2.5 million. Over the whole 2012, the revenue grew by 7.5% to $524.1 million, the statement added.

Nam Tai Electronics, Inc. (NYSE:NTE)

In turnover worth almost $7.4 million, Nam Tai Electronics, Inc. (NYSE:NTE) has lost 29.48% to $7.99. Today, Nam Tai Electronics, Inc. (NYSE:NTE) released its financial results for the first three months of 2013. The net sales advanced to $177.5 million, higher compared to $87.8 million in the first quarter of the previous year. The net income totalled almost $5.0 million, against a loss of $3.6 million, Nam Tai Electronics, Inc. (NYSE:NTE) said in a statement.

China Hgs Real Estate Inc (NASDAQ:HGSH) declined by 25.51% to $9.11. China Hgs Real Estate Inc (NASDAQ:HGSH) is specialized in real estate development, construction and sale of residential apartments, parking as well as commercial properties.

Greenway Medical Technologies, Inc. (NYSE:GWAY) fell by 19.07% to $12.99 in turnover of about $887,900.  In a statement issued today, Greenway Medical Technologies, Inc. (NYSE:GWAY), has reviewed its outlook for the fiscal year that will end on June 30, 2013. The company forecasts a revenue between $132 million and $134 million and an adjusted EBITDA of between %5.8 million to $6.8 million.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) decreased by 18.86% to $1.85 in deals worth $3.2 million. The Street said in a story today that  Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) could suffer after Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE) announced about signing a partnership agreement for the development of Pfizer Inc. (NYSE:PFE)’s ertugliflozin which is being evaluated for the cure of type 2 diabetes. Since Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is designing a similar drug, LX4211, it could have some difficulties finding a partner to help cover the costs of research, The Street said.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!